DTC Defence Therapeutics Inc

0.518

-0.01 (-1.89%)

31 Jul 2024 - Closed

Realtime Data

Share Name	Share Symbol	Market	Type
Defence Therapeutics Inc	TG:DTC	Tradegate	Ordinary Share

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-0.01	-1.89%	0.518	0.50	0.536	0.548	0.486	0.548	27,920	22:50:01

Domtar Announces 2005 Third Quarter Financial Results and Suspends Common Share Dividend

27/10/2005 2:27pm

PR Newswire (US)

Defence Therapeutics (TG:DTC)
Historical Stock Chart

From Aug 2019 to Aug 2024

Click Here for more Defence Therapeutics Charts.

DTC (TSX,NYSE) MONTREAL, Oct. 27 /PRNewswire-FirstCall/ -- Domtar Inc. announced today a net loss of $52 million ($0.23 per common share) in the third quarter of 2005 compared to net earnings of $29 million ($0.13 per common share) in the third quarter of 2004 and net earnings of $2 million ($0.01 per common share) in the second quarter of 2005.